About this episode
Host: Darryl S. Chutka, M.D.
Guest: Stephen Kopecky, M.D.
Cardiovascular disease is highly prevalent in our society. Fortunately, we have a variety of treatment options to lower the risk of developing its complications. Over the past decade, there’ve been many changes in managing hyperlipidemia, one of the most important risk factors for cardiovascular disease. This includes a change in assessing our patients’ risk, identification of new risk factors, new testing options, and new pharmacologic options for treating hyperlipidemia. We’ll cover all of these topics in this podcast. My guest is Dr. Stephen Kopecky, a preventive cardiologist at the Mayo Clinic, and we’ll be discussing “Update in the Management of Hyperlipidemia”.
Connect with us! Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development
Get every episode summarized
Each time Mayo Clinic Talks publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Mayo Clinic Talks
Advancements in the Diagnosis and Treatment of Parkinson’s Disease
Mayo Clinic Talks
Parkinson’s Disease in Children and Young Adults
Mayo Clinic Talks
Mayo Clinic Proceedings: Diabetes and Novel Therapies for Diabetes
Mayo Clinic Talks
Mayo Clinic Proceedings: Healthy Aging
Mayo Clinic Talks